Skip to main content
. 2009 Jun;44(3):988–1009. doi: 10.1111/j.1475-6773.2008.00943.x

Table 2.

Linear Fixed Effects Models of Generic and Brand Prescription Drug Utilization (N=1,074)

Variable Number of Generic rxs PMPQ Number of Brand rxs PMPQ Generic Dispensing Rate (GDR)
Two-tier member cost sharing
Retail coinsurance −0.14676*** −0.06591 −0.00369*
(0.05355) (0.07022) (0.00218)
Retail generic OOP cost 0.04089 0.08753*** 0.00203
(0.02779) (0.02841) (0.00144)
Retail generic OOP cost squared −0.00191 −0.00369** −0.00019**
(0.00158) (0.00167) (0.00007)
Retail brand OOP cost −0.00068 −0.02626*** 0.00185***
(0.00318) (0.00371) (0.00048)
Retail brand OOP cost squared 0.00005 0.00023*** −0.00001
(0.00004) (0.00005) (0.00001)
Mail–retail generic OOP cost ratio 0.07409 0.08903 0.00784**
(0.06215) (0.05609) (0.00366)
Mail–retail generic OOP cost ratio squared −0.00607 −0.01230** −0.00071**
(0.00572) (0.00585) (0.00032)
Mail–retail brand OOP cost ratio −0.20046*** −0.29762*** 0.02063***
(0.04560) (0.05356) (0.00421)
Mail–retail brand OOP cost ratio squared 0.01040*** 0.01442*** −0.00093***
(0.00245) (0.00270) (0.00019)
Three-tier member cost sharing§
Retail coinsurance −0.03202 −0.01371 0.00237
(0.04646) (0.04242) (0.00178)
Retail generic OOP cost −0.02924*** −0.00117 0.00016
(0.00893) (0.00796) (0.00024)
Retail generic OOP cost squared 0.00046*** −0.00000 0.00001*
(0.00015) (0.00013) (0.00001)
Retail P brand OOP cost 0.01825 0.00812 −0.00136**
(0.01418) (0.01736) (0.00066)
Retail P brand OOP cost squared −0.00046** −0.00036 0.00004***
(0.00023) (0.00029) (0.00001)
Retail NP brand OOP cost 0.00539 −0.01147* 0.00220***
(0.00514) (0.00605) (0.00033)
Retail NP brand OOP cost squared −0.00005 0.00009* −0.00002***
(0.00004) (0.00005) (0.00000)
Mail–retail generic OOP cost ratio 0.00711 0.03365* −0.00224
(0.01784) (0.01884) (0.00152)
Mail–retail generic OOP cost ratio squared −0.00155** −0.00281*** 0.00024***
(0.00066) (0.00103) (0.00008)
Mail–retail P brand OOP cost ratio −0.18369 −0.33670 0.01737***
(0.24897) (0.25856) (0.00569)
Mail–retail P brand OOP cost ratio squared 0.05462 0.06557 −0.00374**
(0.06402) (0.06305) (0.00149)
Mail–retail NP brand OOP cost ratio −0.18311 0.09793 −0.01081**
(0.14503) (0.19889) (0.00461)
Mail–retail NP brand OOP cost ratio squared 0.02352 −0.03603 0.00371***
(0.02630) (0.03585) (0.00090)
Other pharmacy benefit design elements
Retail deductible −0.14751*** −0.12812*** −0.00042
(0.03862) (0.02930) (0.00241)
Retail dispense as written penalty (physician) 0.00169 −0.04776 0.01146***
(0.02049) (0.03002) (0.00191)
Retail dispense as written penalty (patient) 0.05308 0.07999 0.00319**
(0.04452) (0.05108) (0.00163)
Retail maximum allowable benefit 0.06779*** 0.05775*** 0.01356***
(0.00847) (0.01371) (0.00125)
Retail maximum out-of-pocket −0.02789 −0.10436 −0.00291
(0.12390) (0.11194) (0.00343)
Mandatory mail 0.00480 0.01394 −0.00320***
(0.00921) (0.00934) (0.00067)

Note: Presented are coefficient estimates with robust Driscoll–Kraay standard errors in parentheses.

Included in models but not reported are 11 plan sponsor characteristic variables, 11 time dummies, and a constant.

Statistic1al significance denoted as:

***

p<.01.

**

p<.05.

*

p<.10.

Prescription drug utilization measures calculated using 30-day supply equivalents (i.e., 1 mail rx=3 retail rxs).

Coefficients and standard errors are of member cost-sharing variables interacted with two-tier plan indicator.

§

Coefficients and standard errors are of member cost-sharing variables interacted with three-tier plan indicator.

NP brand, nonpreferred brand; OOP, out-of-pocket; P brand, preferred brand; PMPQ, per member per quarter.